Literature DB >> 15583601

Lesional T cells and dermal dendrocytes in psoriasis plaque express increased levels of granulysin.

Siba P Raychaudhuri1, W-Y Jiang, Smriti K Raychaudhuri, Alan M Krensky.   

Abstract

Granulysin is a broad-spectrum potent antimicrobial peptide produced by the immunocytes. We determined granulysin levels in certain cutaneous inflammatory diseases and correlated expression of granulysin with the relative risks of secondary infections in these conditions. In immunohistochemistry stains a monoclonal antigranulysin antibody was used at 1:150 dilutions. Compared with atopic dermatitis and nummular eczema lesions where secondary infection with Staphylococcus aureus is very common, we found that a significantly increased number of granulysin-positive T cells (P < .01) were present in psoriatic plaques. Psoriasis plaques are heavily colonized with S aureus . It is a well-known observation that despite open cracks and fissures these plaques do not get infected. Increased levels of granulysin provide an explanation for relative immunity of psoriatic plaques against both gram-positive and gram-negative bacterial infections.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15583601     DOI: 10.1016/j.jaad.2003.10.679

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.

Authors:  Drazen Massari; Larisa Prpic-Massari; Tatjana Kehler; Marija Kastelan; Bozidar Curkovic; Viktor Persic; Alen Ruzic; Gordana Laskarin
Journal:  Rheumatol Int       Date:  2011-08-10       Impact factor: 2.631

2.  The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface.

Authors:  Virginia D Winn; Matthew Gormley; Susan J Fisher
Journal:  Pregnancy Hypertens       Date:  2011-01-01       Impact factor: 2.899

3.  Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin.

Authors:  Poonam Tewary; De Yang; Gonzalo de la Rosa; Yana Li; Michael W Finn; Alan M Krensky; Carol Clayberger; Joost J Oppenheim
Journal:  Blood       Date:  2010-07-21       Impact factor: 22.113

4.  Scid mouse model of psoriasis: a unique tool for drug development of autoreactive T-cell and th-17 cell-mediated autoimmune diseases.

Authors:  Smriti K Raychaudhuri; Siba P Raychaudhuri
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

5.  Changes of antimicrobial peptides and transepidermal water loss after topical application of tacrolimus and ceramide-dominant emollient in patients with atopic dermatitis.

Authors:  Kui Young Park; Dong Ha Kim; Mi Sook Jeong; Kapsok Li; Seong Jun Seo
Journal:  J Korean Med Sci       Date:  2010-04-22       Impact factor: 2.153

Review 6.  Biology and clinical relevance of granulysin.

Authors:  A M Krensky; C Clayberger
Journal:  Tissue Antigens       Date:  2009-03

7.  Granulysin-mediated tumor rejection in transgenic mice.

Authors:  Lisa P Huang; Shu-Chen Lyu; Carol Clayberger; Alan M Krensky
Journal:  J Immunol       Date:  2007-01-01       Impact factor: 5.426

Review 8.  Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions.

Authors:  Shih-Chi Su; Wen-Hung Chung
Journal:  Toxins (Basel)       Date:  2014-01-03       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.